0
Research Letters |

Mortality of Bullous Pemphigoid in China

Jun Li, MD; Ya-Gang Zuo, MD; He-Yi Zheng, MD
JAMA Dermatol. 2013;149(1):106-108. doi:10.1001/archdermatol.2012.2994.
Text Size: A A A
Published online

Extract

Bullous pemphigoid (BP) is the most common acquired autoimmune blistering disorder that occurs mostly in elderly people. The first-year mortality has been reported to range from 6% to 41%.13 This study determined the 1-, 2-, and 5-year mortality of patients with BP in China and identified risk factors affecting survival. The mortality of patients with BP was compared with age-matched persons in the general population.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure. Kaplan-Meier curve of overall survival of patients with bullous pemphigoid.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Mortality of Bullous Pemphigoid in China
Posted on January 30, 2013
Adria Gual MD
Dermatology Department. Hospital Clínic. Universitat de Barcelona
Conflict of Interest: None Declared
We read with interest the study by Li et al1 describing the prognosis of Bullous Pemphigoid (BP) in a large patient cohort in China. The authors report a first year mortality rate significantly lower than those reported in previous European studies. We recently conducted a similar retrospective study in our institution with a cohort of 101 BP patients and also found a first year mortality rate of 12.9%.2 However, after reading the results section, it strikes me that the authors do not provide information about how many patients had a follow-up time of at least 2 years and how many patients had a follow-up time of at least 5 years. As mentioned, the median follow-up time was 3 years. Regarding to this data and in the best scenario, the number of patients with a follow-up time of 5 years or longer would have been of 70. Consequently, 1-year mortality rate would have been calculated from a cohort of 140 patients and 5-year mortality rate would have been estimated from a cohort of 70 patients. Moreover, an indeterminate proportion of the patients lost to follow up from the first to the fifth year after diagnosis could have died. As a result, 5-year mortality would have been significantly higher. In our opinion, the 1-year and 5-year mortality rates are not comparable. Furthermore, the observed 5-year mortality rate is not very reliable. References1. Li J, Zuo YG, Zheng HY. Mortality of Bullous Pemphigoid in China. JAMA Dermatol. 2013; 149(1):106-8.2. Gual A, Mascaró JM Jr, Rojas-Farreras S et al. Mortality of Bullous Pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre. J Eur Acad Dermatol Venereol. 2012; Dec 22. doi: 10.1111/jdv.12065. [Epub ahead of print]
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs